Update - Zayed National Museum and Bahrain Launch Six-Week Archaeologica… Transport - Dubai RTA Introduces Five-Star Rating System for Taxi Companies… Weather - Rain Expected in Some Areas on November 16 as Temperatures Drop…

Send an Inquiry

Fill in the details below and our team will get back to you.

Healthcare 1 min read 111 views

Globalpharma Announces Bold Expansion Plans with 25 New Product Launches in 2025

Globalpharma, a leading pharmaceutical manufacturer in the UAE and a subsidiary of Dubai Investments PJSC, has revealed its ambitious expansion strategy for 2025. The company plans to launch 25 new products spanning key therapeutic areas, including diabetes, cardiovascular health, gastroenterology, and orthopedics. This initiative underscores Globalpharma's commitment to addressing the region's evolving healthcare needs with innovative and accessible solutions.

Transformative Vision

“Globalpharma’s growth aligns with Dubai Investments’ vision of transforming key industries,” said Mohammed Saeed Al Raqbani, General Manager of Dubai Investments Industries & Masharie and Board Director of Globalpharma. “The pharmaceutical sector’s rapid expansion presents significant opportunities, and Globalpharma is strategically positioned to capitalize on these. By focusing on innovation, partnerships, and patient-centric solutions, we aim to establish Dubai Investments as a global leader in the pharmaceutical landscape.”

Enhanced Distribution and Market Access

To support its growth, Globalpharma is enhancing its distribution network to ensure seamless access to its products. By optimizing delivery channels and forging new partnerships, the company is committed to meeting the needs of healthcare practitioners and patients. Additionally, refined market entry strategies are helping the company strengthen its presence in key territories while exploring new markets.

“Our focus in 2025 is innovation, accessibility, and collaboration,” said Basem Albarahmeh, General Manager of Globalpharma. “The introduction of 25 new products highlights our dedication to tackling the region's healthcare challenges. By expanding our nutraceutical and women’s health portfolios and refining market strategies, we are setting the stage for sustained growth.”

Building on 2024 Successes

Globalpharma’s momentum for 2025 follows the successful launch of several innovative products in 2024. Notable launches include:

  • Glovadip (Valsartan + Amlodipine) and RUSET (Rosuvastatin + Ezetimibe) for cardiovascular health.
  • Uriout (Febuxostat) for chronic gout management.
  • MG21 and CG21, inspired by UAE heritage, featuring blends of myrrh, costus, and cloves.

These products exemplify the company’s commitment to innovation and addressing critical healthcare needs.

Industry Engagement

Globalpharma will also participate in DUPHAT 2025, a premier pharmaceutical and healthcare event, where it will showcase its latest solutions and engage with industry leaders. This platform reinforces Globalpharma’s commitment to collaboration and innovation, advancing its mission to deliver high-quality healthcare solutions.

Globalpharma expansionDubai pharmaceutical news2025 product launchesUAE healthcare innovationsDubai Investments PJSCGlobalpharma DUPHAT 2025UAE healthcare sector growth

Related News

More on Healthcare

View all

Comments (0)

Join the conversation

No comments yet. Be the first to share your thoughts!

More News

See all
Business

Big 5 Global 2026: Six French companies to showcase advanced construction technologies in Dubai

Six French companies will present their construction technologies and expertise at Big 5 Global 2026, scheduled to take place from November 23 to 26 at the Dubai World Trade Centre. Supported by Business France, AITENDERS, ALPHI ME, ARIADIS, COMUS, CSTB and QUADRA will showcase solutions across...

Nov 16, 2026 · 3 min
Education

JICE connects UAE students with higher education opportunities in Japan at NAJAH Abu Dhabi 2026

The Japan International Cooperation Center (JICE) welcomed approximately 1,200 visitors to the Japan Pavilion at NAJAH Abu Dhabi 2026, held from October 18 to 21 at ADNEC Centre Abu Dhabi. The initiative introduced students and families to higher education opportunities in Japan through...

Nov 16, 2026 · 2 min
Real Estate

Emirates REIT reports 12% rise in property income as Funds from Operations nearly double in Q3 2026

Emirates REIT (CEIC) PLC reported strong financial results for the nine months ended September 30, 2026, with year-on-year growth in property income, operating profit and Funds from Operations (FFO), alongside improvements in its balance sheet. Equitativa (Dubai) Limited, the manager of Emirates...

Nov 16, 2026 · 2 min
Education

Almasar Alshamil Education outlines vision for future of learning at Education Investment MENA 2026

Almasar Alshamil Education Chief Executive Officer Majed Al Mutairi joined regional education leaders at Education Investment MENA 2026 in Dubai, where discussions focused on the future of learning, the role of technology and the importance of collaboration across the education sector. Held on...

Nov 16, 2026 · 2 min
Trusted by

Our Associates

Brands and organisations that work with Day of Dubai.